| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.21 | 0.0003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.2 | 0.0004 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.2 | 0.0009 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |